当前位置:首页 - 行情中心 - 华东医药(000963) - 财务分析

华东医药

(000963)

  

流通市值:498.21亿  总市值:498.41亿
流通股本:17.53亿   总股本:17.54亿

华东医药(000963)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润9.97亿元,每股收益0.57元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益2608771.18万元,未分配利润2002121.97万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产3990804.26万元,负债1382033.08万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入11,183,450,824.2743,612,009,891.0232,664,143,135.6821,674,928,965.21
营业总成本9,992,872,896.3439,388,881,033.0629,289,598,185.119,418,419,774.58
其他经营收益
营业利润1,200,032,835.824,107,892,890.833,350,590,171.042,243,373,665.84
利润总额1,192,194,345.934,016,462,310.243,262,621,550.612,193,163,350.79
净利润997,161,400.383,410,846,772.452,741,858,261.191,803,329,008.97
每股收益
其他综合收益-80,607,620.6156,368,891.2483,361,634.4123,756,112.05
综合收益总额916,553,779.773,467,215,663.692,825,219,895.61,827,085,121.02
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计21,804,215,872.9521,227,344,934.4722,720,785,150.7221,636,328,948.17
非流动资产:
非流动资产合计18,103,826,691.9917,810,691,386.4517,207,998,049.7617,179,119,992.61
资产总计39,908,042,564.9439,038,036,320.9239,928,783,200.4838,815,448,940.78
流动负债:
流动负债合计13,033,135,267.4613,090,663,656.2214,576,398,430.0413,879,308,222.7
非流动负债:
非流动负债合计787,195,534.95776,366,984.52856,050,673.1821,134,219.99
负债合计13,820,330,802.4113,867,030,640.7415,432,449,103.1414,700,442,442.69
所有者权益(或股东权益):
归属于母公司股东权益合计25,733,074,032.124,811,339,992.9924,132,887,034.3123,751,917,398
股东权益合计26,087,711,762.5325,171,005,680.1824,496,334,097.3424,115,006,498.09
负债和股东权益合计39,908,042,564.9439,038,036,320.9239,928,783,200.4838,815,448,940.78
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计10,503,828,372.2148,473,910,236.8735,850,038,955.9323,360,782,717.91
经营活动现金流出小计11,356,164,134.8444,228,305,865.733,239,187,011.7520,903,934,207.81
经营活动产生的现金流量净额-852,335,762.634,245,604,371.172,610,851,944.182,456,848,510.1
投资活动产生的现金流量:
投资活动现金流入小计74,063.51106,264,743.3174,640,978.358,162,534.16
投资活动现金流出小计391,474,414.771,776,037,156.151,153,032,874.23849,919,602.36
投资活动产生的现金流量净额-391,400,351.26-1,669,772,412.84-1,078,391,895.93-791,757,068.2
筹资活动产生的现金流量:
筹资活动现金流入小计1,132,488,831.324,240,271,213.392,739,973,759.11,937,773,758.02
筹资活动现金流出小计1,097,276,837.137,062,742,873.335,102,611,698.723,471,204,956.52
筹资活动产生的现金流量净额35,211,994.19-2,822,471,659.94-2,362,637,939.62-1,533,431,198.5
汇率变动对现金及现金等价物的影响-4,179,294.34-7,589,821.17-6,921,970.54-116,843,004.4
现金及现金等价物净增加额-1,212,703,414.04-254,229,522.78-837,099,861.9114,817,239
期末现金及现金等价物余额3,523,218,249.864,735,921,663.94,153,051,324.775,004,968,425.68
补充资料:
现金及现金等价物的净增加额--254,229,522.78-14,817,239
最新报告期:2026-05-14
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
长城国瑞证券胡晨曦2.222.392.772026-05-14
中信证券宋硕,陈竹,徐嘉琪2.192.432.692026-05-14
国泰海通张澄,郑琴,余文心2.182.442.772026-05-12
东吴证券冉胜男,朱国广2.192.422.672026-04-30
中金公司夏璐,宋歌,张琎,朱言音2.182.52--2026-04-28
TOP↑